Short Term |
|
|
To identify conventional dosage forms having good potential from various therapeutic segments for attempting to formulate them in to NDDS at a later stage. |
|
|
To Establish our position in Indian Market by adding new products & customers in our portfolio and to Strive for leadership in at least one therapeutic segment. |
|
|
To enter International markets with special focus on Emerging Markets. |
|
Medium Term |
|
|
To develop & manufacture the identified & targeted drugs in NDDS form and commercialize them after seeking National & International regulatory approvals. |
|
|
To Consolidate our presence in the Indian market and to consolidate our position as the leaders in at least one therapeutic segment. |
|
|
To Establish & Spread our activities in the Emerging Markets and to evolve suitable strategies for entering into the markets of US & Europe. |
|
Long Term |
|
|
To become a vertically Integrated Pharma company focusing on development, manufacture & commercialization of APIs, Ready to fill pre formulation Intermediates, Direct compression granules & Formulations. |
|
|
To consolidate our activities in the Emerging markets and strive to establish & consolidate leadership position in at least one or two therapeutic segments. |
|
|
To gear up and enter USA, Europe & other highly regulated markets. |